Market Cap (In INR)
142.38 Billion
Revenue (In INR)
21.77 Billion
Net Income (In INR)
3.13 Billion
Avg. Volume
4.19 Million
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 130.0-358.7
- PE
- -
- EPS
- -
- Beta Value
- 1.665
- ISIN
- INE750C01026
- CUSIP
- Y57686100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Mark B. Saldanha
- Employee Count
- -
- Website
- https://marksanspharma.com
- Ipo Date
- 2002-07-19
- Details
- Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
More Stocks
-
MNHVFMowi ASA
MNHVF
-
SWANENERGYSwan Energy Limited
SWANENERGY
-
RAMCOINDRamco Industries Limited
RAMCOIND
-
WBC
-
2146UT Group Co., Ltd.
2146
-
SCI
-
8163
-
FIRRY